Abstract
The study of the distribution of the cytostatic drugs cisplatin, carboplatin, and oxaliplatin along the kidney may help to understand their different nephrotoxic behavior. Laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) allows the acquisition of trace element images in biological tissues. However, results obtained are affected by several variations concerning the sample matrix and instrumental drifts. In this work, an internal standardization method based on printing an Ir-spiked ink onto the surface of the sample has been developed to evaluate the different distributions and accumulation levels of the aforementioned drugs along the kidney of a rat model. A conventional ink-jet printer was used to print fresh sagittal kidney tissue slices of 4 μm. A reproducible and homogenous deposition of the ink along the tissue was observed. The ink was partially absorbed on top of the tissue. Thus, this approach provides a pseudo-internal standardization, due to the fact that the ablation sample and internal standard take place subsequently and not simultaneously. A satisfactory normalization of LA-ICP-MS bioimages and therefore a reliable comparison of the kidney treated with different Pt-based drugs were achieved even for tissues analyzed on different days. Due to the complete ablation of the sample, the transport of the ablated internal standard and tissue to the inductively coupled plasma-mass spectrometry (ICP-MS) is practically taking place at the same time. Pt accumulation in the kidney was observed in accordance to the dosages administered for each drug. Although the accumulation rate of cisplatin and oxaliplatin is high in both cases, their Pt distributions differ. The strong nephrotoxicity observed for cisplatin and the absence of such side effect in the case of oxaliplatin could explain these distribution differences. The homogeneous distribution of oxaliplatin in the cortical and medullar areas could be related with its higher affinity for cellular transporters such as MATE2-k.
Similar content being viewed by others
References
Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334:115–24. doi:10.1097/MAJ.0b013e31812dfe1e.
Moreno-Gordaliza E, Giesen C, Lázaro A, Esteban-Fernández D, Humanes B, Cañas B, et al. Elemental bioimaging in kidney by LA-ICP-MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies. Anal Chem. 2011;83:7933–40. doi:10.1021/ac201933x.
Yonezawa A, Inui KI. Organic cation transporter OCT/SLC22A and H+/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents. Biochem Pharmacol. 2011;81:563–8. doi:10.1016/j.bcp.2010.11.016.
Husain K, Jagannathan R, Hasan Z, Trammell GL, Rybak LP, Hazelrigg SR, et al. Dose response of carboplatin-induced nephrotoxicity in rats. Pharmacol Toxicol. 2002;91:83–9.
Esteban-Fernández D, Gómez-Gómez MM, Cañas B, Verdaguer JM, Ramírez R, Palacios MA. Speciation analysis of platinum antitumoral drugs in impacted tissues. Talanta. 2007;72:768–73. doi:10.1016/j.talanta.2006.12.012.
Esteban-Fernández D, Verdaguer JM, Ramírez-Camacho R, Palacios MA, Gómez-Gómez MM. Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration. J Anal Toxicol. 2008;32:140–6.
Becker JS. J Mass Spectrom. 2013;48:255–68.
Becker JS, Matusch A, Wu B. Bioimaging mass spectrometry of trace elements—recent advance and applications of LA-ICP-MS: a review. Anal Chim Acta. 2014;835:1–18. doi:10.1016/j.aca.2014.04.048.
Lobinski R, Moulin C, Ortega R. Biochimie. 2006;88:1591–604.
Heeren RMA, McDonnell LA, Amstalden E, Luxembourg SL, Altelaar AFM, Piersma SR. Appl Surf Sci. 2006;252:6827–35.
Gholap DS, Izmer A, De Samber B, Van Elteren JT, Selih VS, Evens R, et al. Anal Chim Acta. 2010;664:19–26.
Zoriy M, Matusch A, Spruss T, Becker JS. Laser ablation inductively coupled plasma mass spectrometry for imaging of copper, zinc, and platinum in thin sections of a kidney from a mouse treated with cis-platin. Int J Mass Spectrom. 2007;260:102–6. doi:10.1016/j.ijms.2006.09.012.
Reifschneider O, Wehe CA, Diebold K, Becker C, Sperling M, Karst U. Elemental bioimaging of haematoxylin and eosin-stained tissues by laser ablation ICP-MS. J Anal At Spectrom. 2013;28:989–93.
Reifschneider O, Wehe CA, Raj I, Ehmcke J, Ciarimboli G, Sperling M, et al. Quantitative bioimaging of platinum in polymer embedded mouse organs using laser ablation ICP-MS. Metallomics. 2013;5:1440–7. doi:10.1039/c3mt00147d.
Bonta M, Lohninger H, Laszlo V, Hegedus B, Limbeck A. Quantitative LA-ICP-MS imaging of platinum in chemotherapy treated human malignant pleural mesothelioma samples using printed patterns as standard. J Anal At Spectrom. 2014;29:2159–67.
Egger AE, Theiner S, Kornauth C, Heffeter P, Berger W, et al. Quantitative bioimaging by LA–ICP-MS: a methodological study on the distribution of Pt and Ru in viscera originating from cisplatin- and KP1339-treated mice. Metallomics. 2014;6. doi:10.1039/C4MT00072B.
Gholap D, Verhulst J, Ceelen W, Vanhaecke F. Use of pneumatic nebulization and laser ablation-inductively coupled plasma-mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug. Anal Bioanal Chem. 2012;402:2121–9. doi:10.1007/s00216-011-5654-3.
Frick DA, Günther D. Fundamental studies on the ablation behaviour of carbon in LA-ICP-MS with respect to the suitability as internal standard. J Anal At Spectrom. 2012;27:1294. doi:10.1039/c2ja30072a.
Becker JS, Becker JS. Imaging of metals, metalloids, and non-metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) in biological tissues. Methods Mol Biol. 2010;656:51–82.
Austin C, Fryer F, Lear J, Bishop D, Hare D, Rawling T, et al. Factors affecting internal standard selection for quantitative elemental bio-imaging of soft tissues by LA-ICP-MS. J Anal At Spectrom. 2011;26:1494. doi:10.1039/c0ja00267d.
Austin C, Hare D, Rawling T, McDonagh AM, Doble PJ. J Anal At Spectrom. 2010;25:722–5.
Konz I, Fernández B, Fernández ML, Pereiro R, González H, Álvarez L, et al. Gold internal standard correction for elemental imaging of soft tissue sections by LA-ICP-MS: element distribution in eye microstructures. Anal Bioanal Chem. 2013;405:3091–6. doi:10.1007/s00216-013-6778-4.
Bellis DJ, Santamaria-Fernandez R. Ink jet patterns as model samples for the development of LA-ICP-SFMS methodology for mapping of elemental distribution with reference to biological samples. J Anal At Spectrom. 2010;25:957. doi:10.1039/b926430b.
Hoesl S, Neumann B, Techritz S, Linscheid MW, Theuring F, Scheler C, et al. Development of a calibration and standardization procedure for LA-ICP-MS using a conventional ink-jet printer for quantification of proteins in electro- and Western-blot assays. J Anal At Spectrom. 2014;450:1282–91. doi:10.1039/c4ja00060a.
Muldoon LL, Pagel MA, Kroll RA, Brummett RE, Doolittle ND, Zuhowski EG, et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res. 2000;6:309–15.
Böhm S, Oriana S, Spatti G, Di Re F, Breasciani G, Pirovano C, et al. Dose intensification of platinum compounds with glutathione protection as induction chemotherapy for advanced ovarian carcinoma. Oncology. 1999;57:115–20.
Wandt H, Birkmann J, Denzel T, Schafer K, Schwab G, Pilz D, et al. Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells: a phase I/II study in advanced ovarian cancer. Bone Marrow Transplant. 1999;23:763–70. doi:10.1038/sj.bmt.1701659.
Humanes B, Lazaro A, Camano S, Moreno-Gordaliza E, Lazaro JA, Blanco-Codesido M, et al. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats. Kidney Int. 2012;82:652–63. doi:10.1038/ki.2012.199.
Todd RC, Lippard SJ. Inhibition of transcription by platinum antitumor compounds. Metallomics. 2009;1:280–91. doi:10.1039/b907567d.
Husain K, Whitworth C, Rybak LP. Time response of carboplatin-induced nephrotoxicity in rats. Pharmacol Res. 2004;50:291–300. doi:10.1016/j.phrs.2004.04.001.
Terada T, Inui KI. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A). Biochem Pharmacol. 2008;75:1689–96. doi:10.1016/j.bcp.2007.12.008.
Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K-I. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family). J Pharmacol Exp Ther. 2006;319:879–86. doi:10.1124/jpet.106.110346.lato.
Acknowledgments
This work was financially supported by the Ministry of Economy and Competitiveness of Spain (CTQ-2011-24585 and CTQ2014-55711-R). The authors want to thank Dr. Heike Traub for her valuable expertise in laser ablation measurements. I. Moraleja also acknowledges Universidad Complutense of Madrid for a predoctoral fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interest
The authors declare that they have no competing interests.
Additional information
Irene Moraleja and Diego Esteban-Fernández contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 1026 kb)
Rights and permissions
About this article
Cite this article
Moraleja, I., Esteban-Fernández, D., Lázaro, A. et al. Printing metal-spiked inks for LA-ICP-MS bioimaging internal standardization: comparison of the different nephrotoxic behavior of cisplatin, carboplatin, and oxaliplatin. Anal Bioanal Chem 408, 2309–2318 (2016). https://doi.org/10.1007/s00216-016-9327-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-016-9327-0